Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UMPS | P11172 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PNP | P00491 | 1/20 | 0.36 |
| ▸ | HSPA8 | P11142 | 1/20 | 0.36 |
| ▸ | PYGL | P06737 | 2/20 | 0.35 |
| ▸ | CDK1 | P06493 | 1/20 | 0.35 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.35 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.35 |
| ▸ | CDK2 | P24941 | 1/20 | 0.35 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | EIF4E | P06730 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30131066 | 0.80 | UMPS (0.41) | UMPSTDP1KDM4ETP53MAPT | |
| SCHEMBL25362377 | 0.80 | UMPS (0.41) | UMPSTDP1KDM4ETP53MAPT | |
| SCHEMBL11895670 | 0.80 | UMPS (0.41) | UMPSTDP1KDM4ETP53MAPT | |
| SCHEMBL23510231 | 0.80 | UMPS (0.41) | UMPSTDP1KDM4ETP53MAPT | |
| SCHEMBL11290857 | 0.73 | PYGL (0.39) | HIF1AKDM4EMAPTPYGLLMNA | |
| SCHEMBL9393256 | 0.73 | HIF1A (0.43) | HIF1ALMNAADORA1THPO | |
| SCHEMBL240028 | 0.73 | HIF1A (0.43) | HIF1ALMNAADORA1THPO | |
| SCHEMBL4436402 | 0.73 | HIF1A (0.43) | HIF1ALMNAADORA1THPO | |
| SCHEMBL11287162 | 0.73 | HIF1A (0.40) | HIF1AKDM4EMAPTPNPPYGL | |
| SCHEMBL5182595 | 0.73 | HIF1A (0.43) | HIF1ALMNAADORA1THPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11738025-B2 | Method for treating coronavirus infections | OYAGEN, INC. (US) | 2023-08-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11738025-B2 | Method for treating coronavirus infections | ACE2, ACE, SARS1 | UMPS 80/4885HIF1A 3054/4885TDP1 2345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.